We found that TRPC3, reported to be predominantly expressed in the prostate stroma34, was downregulated in tumours from patients undergoing anticancer treatments (Supplementary Fig. 1j–k) (ONCOMINE: Datasets “Grasso Prostate” and “Tamura Prostate”). This evidence concerns the gene TRPC3 and neoplasm.